These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30335800)

  • 1. Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria.
    Lee MC; Chiang CY; Lee CH; Ho CM; Chang CH; Wang JY; Chen SM
    PLoS One; 2018; 13(10):e0205807. PubMed ID: 30335800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study.
    Lee MC; Lee CH; Lee MR; Wang JY; Chen SM
    BMC Infect Dis; 2019 Nov; 19(1):936. PubMed ID: 31694558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cumulative dose-dependent effects of metformin on the development of tuberculosis in patients newly diagnosed with type 2 diabetes mellitus.
    Heo E; Kim E; Jang EJ; Lee CH
    BMC Pulm Med; 2021 Sep; 21(1):303. PubMed ID: 34563159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes.
    Lin SY; Tu HP; Lu PL; Chen TC; Wang WH; Chong IW; Chen YH
    Respirology; 2018 Nov; 23(11):1063-1073. PubMed ID: 29943489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment.
    Pan SW; Yen YF; Kou YR; Chuang PH; Su VY; Feng JY; Chan YJ; Su WJ
    Chest; 2018 Jun; 153(6):1347-1357. PubMed ID: 29253553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Metformin Use With End-Stage Renal Disease in Patients With Type 2 Diabetes Mellitus: A Nationwide Cohort Study Under the Pay-for-Performance Program.
    Lee MC; Lee CH; Chang LY; Chang CH; Zhang JF; Lee MR; Wang JY; Chen SM
    J Clin Pharmacol; 2019 Nov; 59(11):1443-1452. PubMed ID: 31163098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin was associated with lower all-cause mortality in type 2 diabetes with acute coronary syndrome: A Nationwide registry with propensity score-matched analysis.
    Jong CB; Chen KY; Hsieh MY; Su FY; Wu CC; Voon WC; Hsieh IC; Shyu KG; Chong JT; Lin WS; Hsu CN; Ueng KC; Lai CL
    Int J Cardiol; 2019 Sep; 291():152-157. PubMed ID: 30905518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus.
    Tseng CH
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study.
    Lee KT; Yeh YH; Chang SH; See LC; Lee CH; Wu LS; Liu JR; Kuo CT; Wen MS
    Medicine (Baltimore); 2017 Jul; 96(28):e7507. PubMed ID: 28700501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Sci Rep; 2021 Jun; 11(1):12400. PubMed ID: 34117321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin and tuberculosis risk in elderly patients with diabetes mellitus.
    Park S; Yang BR; Song HJ; Jang SH; Kang DY; Park BJ
    Int J Tuberc Lung Dis; 2019 Aug; 23(8):924-930. PubMed ID: 31533883
    [No Abstract]   [Full Text] [Related]  

  • 12. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
    Tseng CH
    Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
    Tseng CH
    Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin as a potential protective therapy against tuberculosis in patients with diabetes mellitus: A retrospective cohort study in a single teaching hospital.
    Fu CP; Lee CL; Li YH; Lin SY
    J Diabetes Investig; 2021 Sep; 12(9):1603-1609. PubMed ID: 33550691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
    Tseng CH
    Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment.
    Degner NR; Wang JY; Golub JE; Karakousis PC
    Clin Infect Dis; 2018 Jan; 66(2):198-205. PubMed ID: 29325084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
    Tseng CH
    Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject design.
    Yen FS; Chen W; Wei JC; Hsu CC; Hwu CM
    PLoS One; 2018; 13(10):e0204859. PubMed ID: 30286138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Mar; 8(12):18802-18810. PubMed ID: 27861146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin use and cervical cancer risk in female patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2016 Sep; 7(37):59548-59555. PubMed ID: 27486978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.